Literature DB >> 16278076

Mitochondrial dysfunction in cardiac ischemia-reperfusion injury: ROS from complex I, without inhibition.

Andrew J Tompkins1, Lindsay S Burwell, Stanley B Digerness, Corinne Zaragoza, William L Holman, Paul S Brookes.   

Abstract

A key pathologic event in cardiac ischemia reperfusion (I-R) injury is mitochondrial energetic dysfunction, and several studies have attributed this to complex I (CxI) inhibition. In isolated perfused rat hearts, following I-R, we found that CxI-linked respiration was inhibited, but isolated CxI enzymatic activity was not. Using the mitochondrial thiol probe iodobutyl-triphenylphosphonium in conjunction with proteomic tools, thiol modifications were identified in several subunits of the matrix-facing 1alpha sub-complex of CxI. These thiol modifications were accompanied by enhanced ROS generation from CxI, but not complex III. Implications for the pathology of cardiac I-R injury are discussed.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16278076     DOI: 10.1016/j.bbadis.2005.10.001

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  57 in total

1.  Direct evidence for S-nitrosation of mitochondrial complex I.

Authors:  Lindsay S Burwell; Sergiy M Nadtochiy; Andrew J Tompkins; Sara Young; Paul S Brookes
Journal:  Biochem J       Date:  2006-03-15       Impact factor: 3.857

2.  The coordinated increased expression of biliverdin reductase and heme oxygenase-2 promotes cardiomyocyte survival: a reductase-based peptide counters β-adrenergic receptor ligand-mediated cardiac dysfunction.

Authors:  Bo Ding; Peter E M Gibbs; Paul S Brookes; Mahin D Maines
Journal:  FASEB J       Date:  2010-09-27       Impact factor: 5.191

3.  Different mechanisms of mitochondrial proton leak in ischaemia/reperfusion injury and preconditioning: implications for pathology and cardioprotection.

Authors:  Sergiy M Nadtochiy; Andrew J Tompkins; Paul S Brookes
Journal:  Biochem J       Date:  2006-05-01       Impact factor: 3.857

Review 4.  Mechanisms of sudden cardiac death: oxidants and metabolism.

Authors:  Kai-Chien Yang; John W Kyle; Jonathan C Makielski; Samuel C Dudley
Journal:  Circ Res       Date:  2015-06-05       Impact factor: 17.367

Review 5.  Cytoprotection by the modulation of mitochondrial electron transport chain: the emerging role of mitochondrial STAT3.

Authors:  Karol Szczepanek; Qun Chen; Andrew C Larner; Edward J Lesnefsky
Journal:  Mitochondrion       Date:  2011-09-10       Impact factor: 4.160

Review 6.  Subcellular Energetics and Metabolism: A Cross-Species Framework.

Authors:  Robert H Thiele
Journal:  Anesth Analg       Date:  2017-06       Impact factor: 5.108

7.  Intravenous (-)-epicatechin reduces myocardial ischemic injury by protecting mitochondrial function.

Authors:  Katrina Go Yamazaki; Aleksander Y Andreyev; Pilar Ortiz-Vilchis; Susanna Petrosyan; Ajit S Divakaruni; Sandra E Wiley; Christine De La Fuente; Guy Perkins; Guillermo Ceballos; Francisco Villarreal; Anne N Murphy
Journal:  Int J Cardiol       Date:  2014-05-15       Impact factor: 4.164

8.  Mouse liver protein sulfhydryl depletion after acetaminophen exposure.

Authors:  Xi Yang; James Greenhaw; Qiang Shi; Dean W Roberts; Jack A Hinson; Levan Muskhelishvili; Kelly Davis; William F Salminen
Journal:  J Pharmacol Exp Ther       Date:  2012-10-23       Impact factor: 4.030

9.  Hydrogen sulfide post-conditioning preserves interfibrillar mitochondria of rat heart during ischemia reperfusion injury.

Authors:  Shakila A Banu; Sriram Ravindran; Gino A Kurian
Journal:  Cell Stress Chaperones       Date:  2016-03-07       Impact factor: 3.667

10.  Reduction of infarct size by the therapeutic protein TAT-Ndi1 in vivo.

Authors:  Robert M Mentzer; Joseph Wider; Cynthia N Perry; Roberta A Gottlieb
Journal:  J Cardiovasc Pharmacol Ther       Date:  2013-12-23       Impact factor: 2.457

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.